HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm - PubMed (original) (raw)
HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm
N Richard et al. Virology. 1994 Oct.
Abstract
The mechanism by which Rev facilitates the export, and consequently, the translation of the structural protein mRNAs of the human immunodeficiency virus type 1 remains undefined. Previous immunolocalization has determined that Rev is predominantly in the nucleus with significant accumulation in the nucleolus, a localization consistent with the assumed site of Rev action. To determine whether the subcellular distribution is more dynamic than what was indicated by the original studies, the capacity of Rev to shuttle between the nucleus and cytoplasm was examined. It was observed that treatment of cells with DRB or actinomycin D resulted in a dramatic alteration in Rev distribution, the majority of the protein being found in the cytoplasm. Removal of the drug resulted in a rapid accumulation of Rev in the nucleus indicating that the block to nuclear import was reversible. Subsequent studies indicated that the movement of Rev into the cytoplasm was a passive process while its accumulation in the nucleus was an active one, given that only the latter displayed sensitivity to temperature. Finally, it was demonstrated that, while extensive redistribution of Rev could be attained by inhibition of RNA polymerase I alone, Rev was still capable of inducing expression of HIV structural gene expression under these conditions. Consequently, Rev activity does not appear to be dependent on either an intact nucleolus or the accumulation of the protein in the nucleus.
Similar articles
- Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein.
Wolff B, Cohen G, Hauber J, Meshcheryakova D, Rabeck C. Wolff B, et al. Exp Cell Res. 1995 Mar;217(1):31-41. doi: 10.1006/excr.1995.1060. Exp Cell Res. 1995. PMID: 7867718 - Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention.
D'Agostino DM, Ciminale V, Pavlakis GN, Chieco-Bianchi L. D'Agostino DM, et al. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1063-71. doi: 10.1089/aid.1995.11.1063. AIDS Res Hum Retroviruses. 1995. PMID: 8554903 - Alterations in HIV-1 Rev transport in response to cell stress.
Soros V, Cochrane A. Soros V, et al. Virology. 2001 Feb 15;280(2):199-210. doi: 10.1006/viro.2000.0752. Virology. 2001. PMID: 11162834 - The ins and outs of HIV Rev.
Hope TJ. Hope TJ. Arch Biochem Biophys. 1999 May 15;365(2):186-91. doi: 10.1006/abbi.1999.1207. Arch Biochem Biophys. 1999. PMID: 10328811 Review. - The HIV-1 Rev protein.
Pollard VW, Malim MH. Pollard VW, et al. Annu Rev Microbiol. 1998;52:491-532. doi: 10.1146/annurev.micro.52.1.491. Annu Rev Microbiol. 1998. PMID: 9891806 Review.
Cited by
- Human Retrovirus Genomic RNA Packaging.
Hanson HM, Willkomm NA, Yang H, Mansky LM. Hanson HM, et al. Viruses. 2022 May 19;14(5):1094. doi: 10.3390/v14051094. Viruses. 2022. PMID: 35632835 Free PMC article. Review. - Visualizing Association of the Retroviral Gag Protein with Unspliced Viral RNA in the Nucleus.
Maldonado RJK, Rice B, Chen EC, Tuffy KM, Chiari EF, Fahrbach KM, Hope TJ, Parent LJ. Maldonado RJK, et al. mBio. 2020 Apr 7;11(2):e00524-20. doi: 10.1128/mBio.00524-20. mBio. 2020. PMID: 32265329 Free PMC article. - HIV-1 Rev downregulates Tat expression and viral replication via modulation of NAD(P)H:quinine oxidoreductase 1 (NQO1).
Lata S, Ali A, Sood V, Raja R, Banerjea AC. Lata S, et al. Nat Commun. 2015 Jun 10;6:7244. doi: 10.1038/ncomms8244. Nat Commun. 2015. PMID: 26059226 - Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
Likhoshvai VA, Khlebodarova TM, Bazhan SI, Gainova IA, Chereshnev VA, Bocharov GA. Likhoshvai VA, et al. BMC Genomics. 2014;15 Suppl 12(Suppl 12):S1. doi: 10.1186/1471-2164-15-S12-S1. Epub 2014 Dec 19. BMC Genomics. 2014. PMID: 25564443 Free PMC article. - Viral factors in non-progression.
Wang B. Wang B. Front Immunol. 2013 Dec 24;4:355. doi: 10.3389/fimmu.2013.00355. Front Immunol. 2013. PMID: 24400003 Free PMC article. Review.